These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function. Cerletti C; Bonati M; del Maschio A; Galletti F; Dejana E; Tognoni G; de Gaetano G J Lab Clin Med; 1984 Jun; 103(6):869-77. PubMed ID: 6726057 [TBL] [Abstract][Full Text] [Related]
5. Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it. Durnas C; Cusack BJ Drugs Aging; 1992; 2(1):20-34. PubMed ID: 1554971 [TBL] [Abstract][Full Text] [Related]
7. [Safety of reintroducing platelet-inhibitory doses of aspirin in patients with urticaria or angioedema induced by anti-inflammatory doses]. Vial A; Mathelier-Fusade P; Gaouar H; Leynadier F; Chosidow O; Aractingi S; Francès C Ann Dermatol Venereol; 2009 Jan; 136(1):15-20. PubMed ID: 19171224 [TBL] [Abstract][Full Text] [Related]
8. Blood and saliva salicylate measurement in the monitoring of salicylate therapy. Pérez-Mateo M; Erill S; Cabezas R Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):113-5. PubMed ID: 844929 [TBL] [Abstract][Full Text] [Related]
9. Effects of hemolysis and lipemia on the COBAS salicylate and acetaminophen assays compared to GDS assays. Meany D; Schowinsky J; Clarke W Clin Biochem; 2008 Dec; 41(18):1486-8. PubMed ID: 18950612 [TBL] [Abstract][Full Text] [Related]
10. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of aspirin and its application in canine veterinary medicine. Morton DJ; Knottenbelt DC J S Afr Vet Assoc; 1989 Dec; 60(4):191-4. PubMed ID: 2487727 [TBL] [Abstract][Full Text] [Related]
12. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations. Schwertner HA; McGlasson D; Christopher M; Bush AC Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420 [TBL] [Abstract][Full Text] [Related]
13. Use of fluorescence polarization immunoassay for salicylate to avoid positive/negative interference by bilirubin in the Trinder salicylate assay. Dasgupta A; Zaidi S; Johnson M; Chow L; Wells A Ann Clin Biochem; 2003 Nov; 40(Pt 6):684-8. PubMed ID: 14629809 [TBL] [Abstract][Full Text] [Related]
14. Salicylate levels in a stillborn infant born to a drug-addicted mother, with comments on pathology and analytical methodology. Aterman K; Holzbecher M; Ellenberger HA Clin Toxicol; 1980 May; 16(3):263-8. PubMed ID: 7398214 [TBL] [Abstract][Full Text] [Related]
15. Comparison of pharmacokinetic and pharmacodynamic profiles of aspirin following oral gavage and diet dosing in rats. Kapetanovic IM; Bauer KS; Tessier DM; Lindeblad MO; Zakharov AD; Lubet R; Lyubimov A Chem Biol Interact; 2009 May; 179(2-3):233-9. PubMed ID: 18992230 [TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics of aspirin. Levy G Pediatrics; 1978 Nov; 62(5 Pt 2 Suppl):867-72. PubMed ID: 724339 [TBL] [Abstract][Full Text] [Related]
17. Measuring plasma salicylate concentrations in all patients with drug overdose or altered consciousness: is it necessary? Wood DM; Dargan PI; Jones AL Emerg Med J; 2005 Jun; 22(6):401-3. PubMed ID: 15911944 [TBL] [Abstract][Full Text] [Related]
19. Is non-therapeutic aspirin use in children a problem in South Africa? Donald K; Hall S; Seaton C; Tanyanyiwa D S Afr Med J; 2011 Nov; 101(11):823-8. PubMed ID: 22272965 [TBL] [Abstract][Full Text] [Related]